Feds Ban Landlord Software That Quietly Sets Your Rent
Published Date: 7/16/2026
Notice
Summary
The U.S. government is stopping Willow Bridge Property Company from using RealPage’s pricing software that shares sensitive info with other landlords. This change will help keep rental prices fair and competitive. Willow Bridge must also follow new rules and work with the government, with public comments open for 60 days.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Willow Bridge barred from pricing software
A proposed Final Judgment filed July 6, 2026 would bar Willow Bridge Property Company, LLC from licensing or using revenue-management software that relies on competitively sensitive data and would prohibit Willow Bridge from sharing competitively sensitive information with other landlords.
Obligation to adopt compliance and cooperate
Under the proposed Final Judgment (filed July 6, 2026), Willow Bridge must establish an antitrust compliance policy and cooperate with the United States in the litigation.
Action aims to restore renter competition
The Complaint and Competitive Impact Statement (filed in Civil Action No. 1:24-cv-00710) say plaintiffs brought claims under Sections 1 and 2 of the Sherman Act to stop information-sharing and monopoly conduct they say inflated rents; plaintiffs state their goal is to restore the free market to individuals and families so competition can protect renters.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13623 — United States et al. v. Live Nation Entertainment, Inc.; Proposed Final Judgment and Competitive Impact Statement
The government is making Live Nation and Ticketmaster play fair by breaking up some of their exclusive deals and letting artists, promoters, and venues use other ticket sellers. They’ll also cap fees, share data with artists, and sell some amphitheaters to boost competition. These changes start soon and will be watched closely to keep the music scene open and exciting for everyone.
2026-12353 — Notice Pursuant to the National Cooperative Research and Production Act of 1993-The Institute of Electrical and Electronics Engineers, Inc.
The Institute of Electrical and Electronics Engineers (IEEE) just updated its list of tech standards by adding 100 new ones and revising 22 existing ones. These changes help protect companies from big antitrust lawsuits, limiting damages to actual losses. This update keeps IEEE’s innovation safe and sound, with no new costs or deadlines for the public right now.
2026-12366 — Notice Pursuant to the National Cooperative Research and Production Act of 1993-Information Warfare Research Project Consortium
The Information Warfare Research Project Consortium just updated its team by adding 26 new members and saying goodbye to 9 others. This change helps protect members from big antitrust lawsuits, limiting damages to actual losses. If you’re part of this tech and defense group, keep an eye out for more updates as membership stays open and active.
2026-12365 — Notice Pursuant to the National Cooperative Research and Production Act of 1993-ASTM International
ASTM International has updated its list of ongoing projects that help set important standards, and they’ve told the government about these changes to keep antitrust rules fair. This update affects companies and groups involved in creating these standards, ensuring any legal claims about competition are limited to actual damages. The new list covers work started between December 2025 and February 2026, with details available online—no extra costs or deadlines for the public right now.
2026-12359 — Notice Pursuant to the National Cooperative Research and Production Act of 1993-1EdTech Consortium, Inc.
1EdTech Consortium just updated its membership by adding new members from places like Germany, Chile, India, and several U.S. schools, while some others, including the Bill & Melinda Gates Foundation, have left. These changes keep the group’s antitrust protections active, meaning members are only responsible for actual damages if legal issues arise. No big money changes or new activities are planned, and membership stays open for more to join anytime.
2026-11658 — United States, et al. v. Taiheiyo Cement Corporation, et al.; Proposed Final Judgment and Competitive Impact Statement
The U.S. government is stepping in to stop Taiheiyo Cement and CalPortland from buying Vulcan Material’s ready-mix concrete plants in California because it could hurt competition. To keep things fair, the companies must sell off several plants, trucks, and property rights in Escondido, Oceanside, and Lakeside. People have 60 days to share their thoughts before the deal is finalized, keeping the concrete market strong and fair.
Previous / Next Documents
Previous: 2026-14344 — Government Owned Invention Available for License: Chimeric Antigen Receptors Targeting the Gamma Delta (γδ) T-Cell Receptor
The National Cancer Institute has created special immune tools called CARs that target a rare type of T-cell receptor found on some tough cancers and autoimmune diseases. They’re looking for partners to help develop and license this promising technology, which could lead to new treatments for hard-to-beat illnesses. If you’re in biotech or medicine, now’s the time to jump in and make a difference!
Next: 2026-14346 — Government Owned Invention Available for License: Selective Expansion of Engineered TCR-T Cells for Use in Adoptive Cell Immunotherapy
The National Cancer Institute has invented a cool new way to grow special immune cells called TCR-T cells that can better fight cancer. This method helps companies make more powerful, targeted cell therapies by boosting the right cells and cutting out the extras. If you’re in biotech or cancer treatment, this is your chance to license a game-changing tool that could speed up cancer cures and bring new treatments to patients faster.